Quantitative Prediction of Drug–Drug Interactions Involving Inhibitory Metabolites by Physiologically Based Pharmacokinetic Models: Is it Worth It?

Documenti analoghi

• Response to “Quantitative Prediction of Drug‐Drug Interactions Involving Inhibitory Metabolites by Physiologically Based Pharmacokinetic Models: Is It Worth?”
  di: Templeton, IE, et al.
  Pubblicazione: (2017)
• Quantitative Prediction of Drug–Drug Interactions Involving Inhibitory Metabolites in Drug Development: How Can Physiologically Based Pharmacokinetic Modeling Help?
  di: Templeton, IE, et al.
  Pubblicazione: (2016)
• In Vivo Quantitative Prediction of the Effect of Gene Polymorphisms and Drug Interactions on Drug Exposure for CYP2C19 Substrates
  di: Goutelle, Sylvain, et al.
  Pubblicazione: (2013)
• Are Circulating Metabolites Important in Drug-Drug Interactions? Quantitative Analysis of Risk Prediction and Inhibitory Potency
  di: Yeung, Catherine K, et al.
  Pubblicazione: (2010)
• Physiologically Based Pharmacokinetic Modeling Framework for Quantitative Prediction of an Herb–Drug Interaction
  di: Brantley, S J, et al.
  Pubblicazione: (2014)